Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin plus esomeprazole dose-ranging salvage study in advanced/metastatic melanoma
2006-003978-10Phase 2Active
- Sponsor
- Istituto Superiore di Sanità
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and esomeprazole in melanoma, sponsored by Istituto Superiore di Sanità. Primary endpoints: Objective response, Response duration and 5 more. Started May 2007; status: active.
02
Drugs
cisplatinesomeprazole
03
Conditions
melanoma
Beyond the preview
Go deeper on 2006-003978-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003978-10.